HRT Financial’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.36M | Buy |
231,920
+115,846
| +100% | +$4.17M | 0.04% | 288 |
|
|
2025
Q1 | $3.61M | Buy |
116,074
+70,349
| +154% | +$2.19M | 0.02% | 472 |
|
|
2024
Q4 | $1.17M | Buy |
+45,725
| New | +$1.17M | 0.01% | 865 |
|
|
2024
Q2 | – | Sell |
-130,188
| Closed | -$3.95M | – | 2787 |
|
|
2024
Q1 | $3.95M | Buy |
+130,188
| New | +$3.95M | 0.02% | 326 |
|
|
2023
Q4 | – | Sell |
-103,916
| Closed | -$2.82M | – | 2731 |
|
|
2023
Q3 | $2.82M | Sell |
103,916
-258,823
| -71% | -$7.02M | 0.03% | 440 |
|
|
2023
Q2 | $11.2M | Buy |
+362,739
| New | +$11.2M | 0.1% | 127 |
|
|
2023
Q1 | – | Sell |
-119,689
| Closed | -$4.73M | – | 2890 |
|
|
2022
Q4 | $4.73M | Buy |
+119,689
| New | +$4.73M | 0.07% | 271 |
|
|
2022
Q3 | – | Sell |
-60,283
| Closed | -$2.53M | – | 3221 |
|
|
2022
Q2 | $2.53M | Buy |
+60,283
| New | +$2.53M | 0.03% | 472 |
|
|
2021
Q3 | – | Sell |
-310,887
| Closed | -$12.7M | – | 3436 |
|
|
2021
Q2 | $12.7M | Buy |
+310,887
| New | +$12.7M | 0.12% | 148 |
|
|
2020
Q3 | – | Sell |
-70,234
| Closed | -$3.41M | – | 2172 |
|
|
2020
Q2 | $3.41M | Buy |
+70,234
| New | +$3.41M | 0.1% | 186 |
|